Human Performance Laboratory
Valencell works with The Human Performance Laboratory to conduct internal validation and reliability trials of developing technology. Trials include testing the validation and reliability of heart rate, oxygen consumption, calorie utilization, speed, and distance during exercise using Valencell’s PerformTek^® sensor technology and operating system. The Human Performance Laboratory also coordinates external clinical trials with researchers at academic institutions for external validation.

N.C. State Department of Electrical and Computer Engineering
Valencell has been granted an NSF Phase 2 STTR Award for developing a mobile, wearable, noninvasive blood analyte sensor that can be worn throughout everyday life activities. As part of this STTR Program, Valencell will be working with the Department of Electrical and Computer Engineering at North Carolina State University to generate multiwavelength emitters. Valencell will generate and validate mobile, wearable sensor modules integrating these multiwavelength emitters.

Duke Center for Living
In Spring 2008, Valencell was one of 6 recipients of the NC IDEA award. Valencell used these funds to complete preliminary validation testing of proprietary PerformTek^® sensor technology at the Duke Center for Living. This relationship with Duke medical researchers has grown over the years, and Valencell completed further clinical validation testing in 2010. This partnership resulted in Valencell being awarded a NIH SBIR Phase II grant to clinically validate a scalable and seamless energy expenditure monitoring platform for accurately measuring caloric consumption and expenditure in mass markets. Using cutting edge energy expenditure methods including doubly labeled water, indirect calorimetry at both rest and exercise the scientific team is working to provide a meaningful and useful energy balance metric via Valencell technology. 

Meir Magal, Ph.D., CSCS, CES, Fellow of the American College of Sports Medicine
Dr. Magal completed validation research and presented the research titled Validity and Reliability of an Audio Headset Earbud Sensor for Heart Rate Measurements During Exercise presented at the American College of Sports Medicine www.acsm.org annual meeting in San Francisco, June 2012.

Best Buy Capital
In 2011, Valencell received $5.5 million in a Series B venture investment led by Best Buy Capital. Best Buy Capital was launched by Best Buy Co., Inc. to serve as a corporate venture-capital arm for emerging technologies. Best Buy Capital focuses the Core Fund and the Alpha Fund. The Core fund focuses on investment opportunities for existing business units. Alpha makes direct investments in early-stage companies, such as Valencell, that are developing emerging technologies or inventions unavailable to the marketplace.

TDF
TDF is a Washington DC based venture capital fund focused on the communications sector. They partner with talented entrepreneurs and seek to build competitive and innovative technology and services companies. TDF’s focus is driven by investment themes that share several qualities: large and important problems in communications, an ability to add value through management's investing and operational experience, and the Fund's location and relationships in Washington DC.

True Ventures
True Ventures is the premiere early stage venture capital firm. They invest in the best people who are creating companies in proven high growth sectors of the high tech industry. Since inception in 2006, True Ventures has provided visionary Founders with a trusted, seasoned partner, and they actively facilitate a powerful community to help foster growth and innovation.